A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Cefditoren | CAS 104145-95-1 - Request Quote

Picture of Cefditoren
SZ CAT No:SZ-C137014
CAS No
104145-95-1
Mol.F.
C19H18N6O5S3
Mol.Wt.
506.6
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Cefditoren is chemically (6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((Z)-2-(4-methylthiazol-5-yl)vinyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid. Cefditoren is supplied with detailed characterization data compliant with regulatory guideline. Cefditoren can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cefditoren Pivoxil.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 104145-95-1

Purchase 104145-95-1

Order 104145-95-1

Enquire 104145-95-1

price of 104145-95-1

104145-95-1 Supplier

104145-95-1 Manufacturer

104145-95-1 Exporter

buy high quality Cefditoren

Purchase Cefditoren

Cefditoren suppliers

Cefditoren manufacturers

Cefditoren price

Order Cefditoren

Enquire Cefditoren

Cefditoren cost

Cefditoren Supplier

Cefditoren Distributor

Cefditoren for Method Validation

Cefditoren Pivoxil Reference Standard

Cefditoren for ANDA Filing

Cefditoren for Forced Degradation Studies

Cefditoren Identification Standards

Cefditoren for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,